The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Toxicity of cationic lipids and cationic polymers in gene delivery
Abstract
Gene therapy, as a promising therapeutics to treat genetic or acquired diseases, has achieved exciting development in the past two decades. Appropriate gene vectors can be crucial for gene transfer. Cationic lipids and polymers, the most important non-viral vectors, have many advantages over viral ones as non-immunogenic, easy to produce and not oncogenic. They hold the promise to replace viral vectors to be used in clinic. However, the toxicity is still an obstacle to the application of non-viral vectors to gene therapy. For overcoming the problem, many new cationic compounds have been developed. This article provides a review with respect to toxicity of cationic lipids and polymers in gene delivery. We evaluate the structural features of cationic compounds and summarize the relationship of toxicity and structure and hope to provide available suggestions on the development of these cationic compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEGylated, neutral, and ionizable lipids are employed as stable carriers in lipid delivery systems designed specifically for siRNA, despite toxicity, complement activation, and poor biological distribution also encouraging their development.317,318”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [317]
In the citing paper
“Based on the potential toxicity of liposomes in clinical application,25,26 the success of the first approved small interfering RNA-lipid nanoparticle (LNP) therapeutic27 and mRNA COVID-19 vaccines originates only from their delivery using ionizable lipid-containing LNPs,28, 29, 30”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [25]
In the citing paper
“Cytotoxicity of lipid materials is also a safety concern, depending on the dose, lipid properties and cell types176,177.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [176]
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.
Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y.-L., Border, R., Ramsey, P., Martin, M. U., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,313
Fischer, D., Bieber, T., Li, Y., Elsässer, H., & Kissel, T. (1999) · Pharmaceutical Research · doi:10.1023/a:1014861900478 · Cited by 1,219
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,200
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 998
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19990605)45:3 · Cited by 833
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766
Research works printed but not linked: 1
- Hong, 1997, Stabilisation of cationic liposome/DNA complexes by polyamines and polyethyleneglycol–phospholipid conjugates for efficient in vivo gene delivery, FEBS Lett., 414, 187
Cited by
Sorted by citations
Items 301–400 of 1,000
Petrova, N. S., Chernikov, I. V., Meschaninova, M. I., Dovydenko, I. S., Venyaminova, A. G., Аркадьевна, З. М., Vlassov, V. V., & Chernolovskaya, E. L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1002 · Cited by 96
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides
Hou, K. K., Pan, H., Ratner, L., Schlesinger, P. H., & Wickline, S. A. (2013) · ACS Nano · doi:10.1021/nn403311c · Cited by 95
Zhang, J., Fan, H., Levorse, D. A., & Crocker, L. S. (2011) · Langmuir · doi:10.1021/la104590k · Cited by 96
Li, X., Qi, J., Wang, J., Hu, W., Zhou, W., Wang, Y., & Li, T. (2024) · Theranostics · doi:10.7150/thno.84291 · Cited by 100
Byrne, M., Victory, D., Hibbitts, A., Lanigan, M., Heise, A., & Cryan, S. (2013) · Biomaterials Science · doi:10.1039/c3bm60123d · Cited by 95
Self-assembled polysaccharide nanostructures for controlled-release applications
Myrick, J. M., Vendra, V. K., & Krishnan, S. (2014) · Nanotechnology Reviews · doi:10.1515/ntrev-2012-0050 · Cited by 98
Zhang, Y., Chen, X., Lan, J., You, J., & Chen, L. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00858.x · Cited by 95
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis
Zhou, H.-F., Yan, H., Pan, H., Hou, K. K., Akk, A. M., Springer, L. E., Hu, Y., Allen, J. S., Wickline, S. A., & Pham, C. T. N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75673 · Cited by 95
Dong, Y., Chen, Y., Zhu, D., Shi, K., Ma, C., Zhang, W., Rocchi, P., Jiang, L., & Liu, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.003 · Cited by 94
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
Tawfik, M., Chen, F., Goldberg, J. L., & Sabel, B. A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02287-3 · Cited by 96
Nuclease-Resistant DNA via High-Density Packing in Polymeric Micellar Nanoparticle Coronas
Rush, A. M., Thompson, M. P., Tatro, E. T., & Gianneschi, N. C. (2013) · ACS Nano · doi:10.1021/nn305030g · Cited by 94
Engineering nanoparticle toolkits for mRNA delivery
Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 96
Momoh, F. U., Boateng, J. S., Richardson, S. C. W., Chowdhry, B. Z., & Mitchell, J. C. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.07.037 · Cited by 93
Raouane, M., Desmaële, D., Gilbert-Sirieix, M., Gueutin, C., Zouhiri, F., Bourgaux, C., Lepeltier, É., Gref, R., Salah, R. B., Clayman, G. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000272 · Cited by 93
Cancer nanotheranostics: Strategies, promises and impediments
Chowdhury, M. R., Schumann, C., Bhakta-Guha, D., & Guha, G. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.035 · Cited by 96
Laird, N. Z., Acri, T. M., Tingle, K., & Salem, A. K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.009 · Cited by 93
Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery
He, Z., Zheng, X. E., Wu, X. H., Song, X. R., He, G., Wu, W. F., Yu, S., Mao, S. J., & Wei, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.029 · Cited by 92
Strand, S. P., Issa, M. M., Christensen, B. E., Vårum, K. M., & Artursson, P. (2008) · Biomacromolecules · doi:10.1021/bm800832u · Cited by 92
Optimization and characterization of anionic lipoplexes for gene delivery
Srinivasan, C., & Burgess, D. J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.022 · Cited by 92
Gene Delivery Properties of End-Modified Poly(β-amino ester)s
Zugates, G. T., Tedford, N. C., Zumbuehl, A., Jhunjhunwala, S., Kang, C. S., Griffith, L. G., Lauffenburger, D. A., Langer, R., & Anderson, D. G. (2007) · Bioconjugate Chemistry · doi:10.1021/bc7002082 · Cited by 92
Intelligent nucleic acid delivery systems based on stimuli-responsive polymers
Du, F., Wang, Y., Zhang, R., & Li, Z. (2009) · Soft Matter · doi:10.1039/b915020j · Cited by 91
Non-viral nanocarriers for intracellular delivery of microRNA therapeutics
Bai, Z., Wei, J., Yu, C., Han, X., Qin, X., Zhang, C., Liao, W., Li, L., & Huang, W. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb02946f · Cited by 93
Biomimetic noncationic lipid nanoparticles for mRNA delivery
Wang, C., Zhao, C., Wang, W., Liu, X., & Deng, H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311276120 · Cited by 91
Melittin derived peptides for nanoparticle based siRNA transfection
Hou, K. K., Pan, H., Lanza, G. M., & Wickline, S. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.037 · Cited by 91
Mendonça, L. S., Firmino, F., Moreira, J. N., de Lima, M. C. P., & Simões, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9004365 · Cited by 92
Direct Cytosolic Delivery of siRNA Using Nanoparticle‐Stabilized Nanocapsules
Jiang, Y. Y., Tang, R., Duncan, B., Jiang, Z., Yan, B., Mout, R., & Rotello, V. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409161 · Cited by 90
Obuobi, S. A. O., Julin, K., Fredheim, E. G. A., Johannessen, M., & Škalko‐Basnet, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.002 · Cited by 90
Zhang, Y., Peng, L., Mumper, R. J., & Huang, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.050 · Cited by 90
Clinical therapies and nano drug delivery systems for urinary bladder cancer
Jain, P., Kathuria, H., & Momin, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107871 · Cited by 89
Polymers and surfactants at fluid interfaces studied with specular neutron reflectometry
Braun, L., Uhlig, M., von Klitzing, R., & Campbell, R. A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.07.005 · Cited by 89
Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.
Geretto, M., Pulliero, A., Rosano, C., Zhabayeva, D., Bersimbaev, R. I., & Izzotti, A. (2017) · PubMed Central · Cited by 89
Transcription and Translation Inhibitors in Cancer Treatment
Laham-Karam, N., Pinto, G., Poso, A., & Kokkonen, P. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00276 · Cited by 93
Xiao, D., Li, Y., Tian, T., Zhang, T., Shi, S., Lu, B., Gao, Y., Qin, X., Zhang, M., Wei, W., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c23005 · Cited by 89
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors
Salzano, G., Marra, M., Porru, M., Zappavigna, S., Abbruzzese, A., Rotonda, M. I. L., Leonetti, C., Caraglia, M., & Rosa, G. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.046 · Cited by 89
Segovia, N., Dosta, P., Cascante, A., Ramos, V., & Borrós, S. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.054 · Cited by 89
Silk fibroin layer-by-layer microcapsules for localized gene delivery
Li, L., Puhl, S., Meinel, L., & Germershaus, O. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.062 · Cited by 89
Habrant, D., Peuziat, P., Colombani, T., Dallet, L., Gehin, J., Emilie, G., Berangere, E., Lambert, O., Haudebourg, T., & Pitard, B. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01679 · Cited by 91
Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
Guzman‐Villanueva, D., El-sherbiny, I. M., Herrera‐Ruiz, D., Vlassov, A. V., & Smyth, H. D. C. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23300 · Cited by 90
Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems
Wang, Y., Ye, M., Xie, R., & Gong, S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00749 · Cited by 92
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Ren, H., Jia, W., Xie, Y., Yu, M., & Chen, Y. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00848c · Cited by 91
Hagedorn, L., Jürgens, D. C., Merkel, O. M., & Winkeljann, B. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2024.19 · Cited by 93
Ostrowski, N. J., Lee, B., Enick, N., Carlson, B., Kunjukunju, S., Roy, A., & Kumta, P. N. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.05.010 · Cited by 88
Zuo, L., Huang, Z., Dong, L., Xu, L., Zhu, Y., Zeng, K., Zhang, C., Chen, J., & Zhang, J. (2009) · Gut · doi:10.1136/gut.2009.184556 · Cited by 88
Effect of acyl chain length on transfection efficiency and toxicity of polyethylenimine
Aravindan, L., Bicknell, K. A., Brooks, G., Khutoryanskiy, V. V., & Williams, A. C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.052 · Cited by 88
Nanovesicles engineered from ES cells for enhanced cell proliferation
Jeong, D., Jo, W., Yoon, J., Kim, J., Gianchandani, S., Gho, Y. S., & Park, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.047 · Cited by 89
Liu, C., & Zhang, N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00013-9 · Cited by 90
Yan, J., Zhang, C., Zhao, Y., Cao, C., Wu, K., Zhao, L., & Zhang, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.089 · Cited by 87
Self-citationMagnetoliposomes as magnetic resonance imaging contrast agents
Soenen, S. J., Velde, G. V., Ketkar-Atre, A., Himmelreich, U., & Cuyper, M. D. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.122 · Cited by 87
Injectable, Guest–Host Assembled Polyethylenimine Hydrogel for siRNA Delivery
Wang, L. L., Sloand, J. N., Gaffey, A. C., Venkataraman, C. M., Wang, Z., Trubelja, A., Hammer, D. A., Atluri, P., & Burdick, J. A. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01378 · Cited by 88
Gonzalez‐Fernandez, T., Sathy, B. N., Hobbs, C. J., Cunniffe, G. M., McCarthy, H. O., Dunne, N., Nicolosi, V., O’Brien, F. J., & Kelly, D. J. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.03.044 · Cited by 89
Jia, Y. P., Shi, K., Liao, J., Peng, J., Hao, Y., Qu, Y., Chen, L. J., Liu, L., Yuan, X., Qian, Z. Y., et al. (2020) · Small Methods · doi:10.1002/smtd.201900799 · Cited by 87
Biomaterial-based delivery of nucleic acids for tissue regeneration
Zhuang, Y., & Cui, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113885 · Cited by 88
Lin, P., Cheng, X., Zhuo, R., Lan, J. Q., Wang, Y., Shi, B., & Li, S. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32117 · Cited by 87
Kwok, A., Eggimann, G. A., Reymond, J., Darbre, T., & Hollfelder, F. (2013) · ACS Nano · doi:10.1021/nn400343z · Cited by 87
Magadala, P., & Amiji, M. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9065-0 · Cited by 87
Nanoparticles as transfection agents: a comprehensive study with ten different cell lines
Neuhaus, B., Tosun, B., Rotan, O., Frede, A., Westendorf, A. M., & Epple, M. (2016) · RSC Advances · doi:10.1039/c5ra25333k · Cited by 87
Worley, B. V., Slomberg, D. L., & Schoenfisch, M. H. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5000719 · Cited by 87
miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
Chitkara, D., Mittal, A., & Mahato, R. I. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.006 · Cited by 86
Graphene-Based Platforms for Cancer Therapeutics
Patel, S. C., Lee, S., Lalwani, G., Suhrland, C., Chowdhury, S. M., & Sitharaman, B. (2016) · Therapeutic Delivery · doi:10.4155/tde.15.93 · Cited by 86
Polymeric Nucleic Acid Vehicles Exploit Active Interorganelle Trafficking Mechanisms
Fichter, K. M., Ingle, N. P., McLendon, P. M., & Reineke, T. M. (2012) · ACS Nano · doi:10.1021/nn304218q · Cited by 86
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
Hyeon, L. S., Kang, Y. Y., Jang, H.-E., & Mok, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.009 · Cited by 89
Cationic micelle: A promising nanocarrier for gene delivery with high transfection efficiency
Wang, H., Ding, S., Zhang, Z., Wang, L., & You, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3101 · Cited by 85
Rational design of cationic cyclooligosaccharides as efficient gene delivery systems
Díaz‐Moscoso, A., Balbuena, P., Gómez-Garcı́a, M., Mellet, C. O., Benito, J. M., Gourriérec, L. L., Giorgio, C. D., Vierling, P., Mazzaglia, A., Micali, N. L., et al. (2008) · Chemical Communications · doi:10.1039/b718672j · Cited by 84
Ming, X., Alam, M. R., Fisher, M. H., Yan, Y., Chen, X. S., & Juliano, R. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq534 · Cited by 85
Recent advances in the use of nanoparticles for allergen‐specific immunotherapy
Pohlit, H., Bellinghausen, I., Frey, H., & Saloga, J. (2017) · Allergy · doi:10.1111/all.13199 · Cited by 84
Different sourced extracellular vesicles and their potential applications in clinical treatments
Bahmani, L., & Ullah, M. (2022) · Cells · doi:10.3390/cells11131989 · Cited by 83
Doktorovová, S., Santos, D. L., Costa, I. H. D. S. E., Andreani, T., Souto, E. B., & Silva, A. M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.011 · Cited by 83
Polyethylenimine Is a Strong Inhibitor of Human Papillomavirus and Cytomegalovirus Infection
Spoden, G. A., Besold, K., Krauter, S., Plachter, B., Hanik, N., Kilbinger, A. F. M., Lambert, C., & Florin, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05147-11 · Cited by 83
Devalliere, J., Chang, W. G., Andrejecsk, J. W., Abrahimi, P., Cheng, C. J., Jane‐wit, D., Saltzman, W. M., & Pober, J. S. (2014) · The FASEB Journal · doi:10.1096/fj.13-238527 · Cited by 83
Gene regulation with carbon-based siRNA conjugates for cancer therapy
Zhang, L., Zheng, W., Tang, R., Wang, N., Zhang, W., & Jiang, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.015 · Cited by 83
Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles
Brown, D. W., Wee, P., Bhandari, P., Bukhari, A. B., Grin, L., Vega, H., Hejazi, M., Sosnowski, D. L., Ablack, J., Clancy, E. K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.023 · Cited by 84
Lipid-based vectors for siRNA delivery
Zhang, S., Zhi, D., & Huang, L. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.719232 · Cited by 83
Self-citationBiomaterials in siRNA Delivery: A Comprehensive Review
Ho, W., Zhang, X., & Xu, X. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600418 · Cited by 85
Cellular Deformations Induced by Conical Silicon Nanowire Arrays Facilitate Gene Delivery
Chen, Y., Aslanoglou, S., Gervinskas, G., Abdelmaksoud, H. H., Voelcker, N. H., & Elnathan, R. (2019) · Small · doi:10.1002/smll.201904819 · Cited by 85
Materials for Improving Immune Cell Transfection
Kumar, A. R. K., Shou, Y., Chan, B., Krishaa, L., & Tay, A. K. P. (2021) · Advanced Materials · doi:10.1002/adma.202007421 · Cited by 83
Controlled delivery of antisense oligonucleotides: a brief review of current strategies
Zhao, X., Pan, F., Holt, C. M., Lewis, A. L., & Lu, J. R. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902992894 · Cited by 82
Click-Modified Anandamide siRNA Enables Delivery and Gene Silencing in Neuronal and Immune Cells
Willibald, J., Harder, J., Sparrer, K. M. J., Conzelmann, K., & Carell, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303251f · Cited by 82
Azarnezhad, A., Samadian, H., Jaymand, M., Sobhani, M., & Ahmadi, A. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1719974 · Cited by 84
Perfluorocarbons in Chemical Biology
Miller, M. A., & Sletten, E. M. (2020) · ChemBioChem · doi:10.1002/cbic.202000297 · Cited by 85
Vesicular drug delivery for the treatment of topical disorders: current and future perspectives
Witika, B. A., Mweetwa, L. L., Tshiamo, K. O., Edler, K. J., Matafwali, S. K., Ntemi, P. V., Chikukwa, M. T. R., & Makoni, P. A. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab082 · Cited by 86
Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles
Mo, Y., Cheng, M. H. Y., D’Elia, A., Doran, K., Ding, L., Chen, J., Cullis, P. R., & Zheng, G. (2023) · ACS Nano · doi:10.1021/acsnano.2c10936 · Cited by 84
Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells
Vlachy, N., Touraud, D., Heilmann, J., & Kunz, W. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.12.038 · Cited by 81
Peng, S., Liu, J.-S., Qin, Y., Wang, H., Cao, B., Lu, L., & Yu, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15037 · Cited by 80
Li, H., Guo, H., Lei, C., Liu, L., Xu, L., Feng, Y., Ke, J., Fang, W., Song, H., Xu, C., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904535 · Cited by 80
Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs
Song, D., Zhao, Y., Wang, Z., & Xu, Q. (2024) · Advanced Materials · doi:10.1002/adma.202401445 · Cited by 87
Multicompartmental Particles for Combined Imaging and siRNA Delivery
Misra, A. C., Bhaskar, S., Clay, N. E., & Lahann, J. (2012) · Advanced Materials · doi:10.1002/adma.201200372 · Cited by 83
Nanoparticles as Nonviral Gene Delivery Vectors
Ragusa, A., Garcı́a, I., & Penadés, S. (2007) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2007.908996 · Cited by 80
Johnson, R. N., Chu, D. S. H., Shi, J., Schellinger, J. G., Carlson, P. M., & Pun, S. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.009 · Cited by 79
Highly efficient gene silencing and bioimaging based on fluorescent carbon dots in vitro and in vivo
Kim, S., Choi, Y., Park, G., Won, C., Park, Y., Lee, Y., Kim, B., & Min, D. (2016) · Nano Research · doi:10.1007/s12274-016-1309-1 · Cited by 79
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
Alfagih, I. M., Aldosari, B. N., AlQuadeib, B. T., Almurshedi, A. S., & Alfagih, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010045 · Cited by 80
Li, L., Song, P., Wang, X., He, B., Li, J., Lai, Xu, & Gu, Z. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33923 · Cited by 79
Maslov, M. A., Kabilova, T. O., Petukhov, I. A., Morozova, N. G., Serebrennikova, G. A., Vlassov, V. V., & Аркадьевна, З. М. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.023 · Cited by 80
Low cytotoxic tissue adhesive based on oxidized dextran and epsilon‐poly‐ l ‐lysine
Hyon, S., Nakajima, N., Sugai, H., & Matsumura, K. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34923 · Cited by 79
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Sun, Y., Sha, Y., Cui, G., Meng, F., & Zhong, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114624 · Cited by 78
Jones, S. P., Gabrielson, N. P., Wong, C., Chow, H., Pack, D. W., Posocco, P., Fermeglia, M., Pricl, S., & Smith, D. K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100260c · Cited by 79
Kostiainen, M. A., Szilvay, G. R., Lehtinen, J., Smith, D. K., Linder, M. B., Urtti, A. O., & Ikkala, O. T. (2007) · ACS Nano · doi:10.1021/nn700053y · Cited by 78
Hatakeyama, H., Murata, M., Sato, Y., Takahashi, M. M., Minakawa, N., Matsuda, A., & Harashima, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.023 · Cited by 78
Astolfi, P., Giorgini, E., Gambini, V., Rossi, B., Vaccari, L., Vita, F., Francescangeli, O., Marchini, C., & Pisani, M. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b03173 · Cited by 78
Sun, X., Dong, S., Li, X., Yu, K., Sun, F., Lee, R. J., Li, Y., & Teng, L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102017 · Cited by 78
Gene Therapy for Human Sensorineural Hearing Loss
Ren, Y., Landegger, L. D., & Stanković, K. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00323 · Cited by 78
Metadata
- Authors
- Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- Dalian Minzu University (CN)
- Sichuan University of Science and Engineering (CN)
- Corresponding author
- Zhang, Shubiao
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 114
- Issue
- 1
- Pages
- 100-109
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2000136129
- Cited by
- 2,286
- References
- 107
- Citations by year
- 2026: 100 · 2025: 123 · 2024: 163 · 2023: 141 · 2022: 146 · 2021: 149 · 2020: 140 · 2019: 168 · 2018: 129 · 2017: 133 · 2016: 124 · 2015: 126 · 2014: 147 · 2013: 117 · 2012: 97
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Dalian Institute of Chemical Physics, CAS Institutional Repository (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- cationic lipids, cationic polymers, gene delivery, non-viral vectors, toxicity, structure-toxicity relationship, gene therapy, cationic compounds
- MeSH terms
- Animals, Cations, Lipids, Liposomes, Polylysine, Polymers, Polysaccharides, Genetic Therapy, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review